January 13, 2025
The study will assess the safety, tolerability, and pharmacokinetics of PMN310 in individuals with mild cognitive impairment or early-stage AD.
January 13, 2025
Your daily dose of the clinical news you may have missed.
January 10, 2025
Caissa Troutman, MD, an obesity medicine and family medicine physician, emphasizes early treatment of obesity, along with HTN management, can improve patient outcomes.
January 10, 2025
Treatments with the investigational rescue medication achieved clinically effective epinephrine levels faster than intramuscular injection.
January 09, 2025
The trial builds on results from a previous phase 1 study that showed dose-dependent weight loss and favorable tolerability for VK2735 in people with obesity.
January 09, 2025
Your daily dose of the clinical news you may have missed.
January 08, 2025
The FDA approved the addition of Guillain-Barré syndrome warnings for Abrysvo and Arexvy, citing postmarketing data suggesting an increased risk.
January 08, 2025
Your daily dose of the clinical news you may have missed.
January 07, 2025
The updated guidelines include 19 recommendations related to the diagnosis and management of eosinophilic esophagitis.
January 07, 2025
Your daily dose of the clinical news you may have missed.